Haiying Liu1, Houlin Zeng2, Weidong Wang2, Qiulan Deng1, Immaculada Margarit3, C Daniela Rinaudo3, Todd Swarthout4, Marianne Cunnington5, Wenjing Ji6, Guozhu Geng6. 1. Guangzhou Women and Children's Medical Center, Guangzhou Medical University Guangzhou, China. 2. Changsha Hospital for Maternal and Child Health Changsha, China. 3. Novartis Vaccines and Diagnostics Srl Siena, Italy - A GSK Company. 4. GlaxoSmithKline B.V. Amsterdam, Netherlands. 5. GlaxoSmithKline Plc United Kingdom. 6. GlaxoSmithKline (China) Investment Co Ltd Shanghai, China.
Abstract
OBJECTIVES: To estimate the incidence, case fatality ratio and serotypes associated with early-onset (EOD) and late-onset (LOD) invasive GBS disease in infants in southern mainland China. METHODS: During the six-month study period, infants aged ≤ 90 days with culture-confirmed GBS disease born in the study hospitals or elsewhere, but presenting to a study hospital, were enrolled. GBS-positive cultures were genotyped, serotyped and sequence typed. The incidence rate was calculated for infants born in the study hospitals, and case fatality ratio and causative serotypes identified for all enrolled GBS cases. RESULTS: Ten cases were enrolled: 2 EOD cases born in the study hospitals and 8 LOD cases born elsewhere. Incidence rate was 0.28 (95% confidence interval: 0.08-1.03, n = 2/7061 successfully followed-up consenting subjects); no cases resulted in fatality. In the 8 GBS isolates available for typing, 4 serotypes (Ia, Ib, III and V) and 5 multi-locus sequence types (1, 10, 12, 17 and 23) were identified. CONCLUSIONS: This is the first study specifically investigating the incidence of GBS invasive disease in infants in southern mainland China. Incidence and case fatality were low but further research is needed in larger, more diverse cohorts to estimate disease burden for the broader Chinese population.
OBJECTIVES: To estimate the incidence, case fatality ratio and serotypes associated with early-onset (EOD) and late-onset (LOD) invasive GBS disease in infants in southern mainland China. METHODS: During the six-month study period, infants aged ≤ 90 days with culture-confirmed GBS disease born in the study hospitals or elsewhere, but presenting to a study hospital, were enrolled. GBS-positive cultures were genotyped, serotyped and sequence typed. The incidence rate was calculated for infants born in the study hospitals, and case fatality ratio and causative serotypes identified for all enrolled GBS cases. RESULTS: Ten cases were enrolled: 2 EOD cases born in the study hospitals and 8 LOD cases born elsewhere. Incidence rate was 0.28 (95% confidence interval: 0.08-1.03, n = 2/7061 successfully followed-up consenting subjects); no cases resulted in fatality. In the 8 GBS isolates available for typing, 4 serotypes (Ia, Ib, III and V) and 5 multi-locus sequence types (1, 10, 12, 17 and 23) were identified. CONCLUSIONS: This is the first study specifically investigating the incidence of GBS invasive disease in infants in southern mainland China. Incidence and case fatality were low but further research is needed in larger, more diverse cohorts to estimate disease burden for the broader Chinese population.
Entities:
Keywords:
China; Group B Streptococcus; case fatality; incidence; infants; serotype
Authors: Shannon D Manning; A Cody Springman; Erica Lehotzky; Maggi A Lewis; Thomas S Whittam; H Dele Davies Journal: J Clin Microbiol Date: 2009-01-21 Impact factor: 5.948
Authors: Nicola Jones; John F Bohnsack; Shinji Takahashi; Karen A Oliver; Man-Suen Chan; Frank Kunst; Philippe Glaser; Christophe Rusniok; Derrick W M Crook; Rosalind M Harding; Naiel Bisharat; Brian G Spratt Journal: J Clin Microbiol Date: 2003-06 Impact factor: 5.948
Authors: Joon-Ho Lee; Hye Kyung Cho; Kyung-Hyo Kim; Chang Hwi Kim; Dong Soo Kim; Kwang Nam Kim; Sung-Ho Cha; Sung Hee Oh; Jae Kyun Hur; Jin Han Kang; Jong Hyun Kim; Yun-Kyung Kim; Young Jin Hong; Eun Hee Chung; Soo-Eun Park; Young Youn Choi; Jung Soo Kim; Hwang Min Kim; Eun Hwa Choi; Hoan Jong Lee Journal: J Korean Med Sci Date: 2011-01-24 Impact factor: 2.153
Authors: Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag Journal: Clin Infect Dis Date: 2017-11-06 Impact factor: 20.999